FDA Approved: IBANDRONATE SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's ibandronate sodium as an original-application generic product for postmenopausal osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• IBANDRONATE SODIUM (ibandronate sodium)

Snippet

ORIG AP for IBANDRONATE SODIUM (IBANDRONATE SODIUM)